Peripheral neuropathies and anti-glycolipid antibodies
The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
Abstract
This review charts the progress of anti-glycolipid antibodies in neuropathy, from their original discovery 20 years ago in immunoglobulin M paraproteinaemic neuropathy through to current discoveries mapping their relationship to subtypes of Guillain-Barré syndrome. Antibodies to >20 different glycolipids have now been associated with a wide range of clinically identifiable acute and chronic neuropathy syndromes. Particular progress has been achieved in understanding the link between acute motor axonal neuropathy and antibodies to GM1, GD1a, GM1b and GalNAc-GD1a, and between the cranial, bulbar and sensory variants of GBS and antibodies to the disialylated gangliosides GQ1b, GT1a, GD1b and GD3. In addition to clinical and serological studies, the origins and measurement of anti-glycolipid antibodies and their relationships to similar carbohydrate structures on infectious organisms, particularly Campylobacter jejuni, are discussed in the context of a molecular mimicry hypothesis. The structure and nomenclature of relevant glycolipids are outlined, along with information on their localization in nerve, and the influence this has on clinical phenotypes. Major advances have been made in animal modelling of anti-glycolipid antibody-associated diseases, both in vitro and in vivo. This has advanced our understanding of the role of anti-GQ1b antibodies in Miller Fisher syndrome with particular respect to the motor nerve terminal as a potential site of injury, and led to the creation of rabbit models of anti-GD1b and anti-GM1 antibody-mediated sensory and motor neuropathy, respectively. With such information in place, it will now be possible to determine the precise mechanisms by which antibodies injure the different compartments of peripheral nerve and establish how a range of immunomodulating therapies, including current treatments, exert their therapeutic effects. Despite these very significant advances, considerable gaps in our knowledge persist, and it is likely that other pathogenic pathways operate in inflammatory neuropathy that are unrelated to glycolipid antibodies, although these are outside the scope of this review.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the latter instance rare human immune responses against the ganglioside-like structures can even result in serious illness, with the complementfi xing antibodies damaging peripheral nerves (Guillain-Barré syndrome) (990 -991).”
From Biological roles of glycans (2017) · cites this paper as [990]
Citations
Cites
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
van der Meché, F. G. A., Schmitz, P. I. M., & the Dutch Guillain–Barré Study Group* (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261705 · Cited by 1,143
Fisher, M. (1956) · New England Journal of Medicine · doi:10.1056/nejm195607122550201 · Cited by 1,069
Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome
Hadden, R. D. M., Cornblath, D. R., Hughes, R. A. C., Zielasek, J., Hartung, H. ‐., Toyka, K. V., Swan, A. V., & The Plasma Exchange/Sandoglobulin Guillain‐Barré Syndrome Trial Group (1998) · Annals of Neurology · doi:10.1002/ana.410440512 · Cited by 942
The spectrum of antecedent infections in Guillain-Barré syndrome: A case-control study
Jacobs, B. C., Rothbarth, P. H., van der Meché, F. G. A., Herbrink, P., Schmitz, P. I. M., de Klerk, M. A., & van Doorn, P. A. (1998) · Neurology · doi:10.1212/wnl.51.4.1110 · Cited by 826
Defining criteria for autoimmune diseases (Witebsky's postulates revisited)
Rose, N. R., & Bona, C. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90244-f · Cited by 814
Campylobacter jejuni Infection and Guillain–Barré Syndrome
Rees, J. H., Soudain, S. E., Gregson, N. A., & Hughes, R. A. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511233332102 · Cited by 753
THE INFLAMMATORY LESION IN IDIOPATHIC POLYNEURITIS
ASBURY, A. K., ARNASON, B. G., & ADAMS, R. D. (1969) · Medicine · doi:10.1097/00005792-196905000-00001 · Cited by 723
Chiba, A., Kusunoki, S., Obata, H., Machinami, R., & Kanazawa, I. (1993) · Neurology · doi:10.1212/wnl.43.10.1911 · Cited by 705
[10] Gangliosides: Structure, isolation, and analysis
Ledeen, R. W., & Yu, R. K. (1982) · Methods in Enzymology · doi:10.1016/0076-6879(82)83012-7 · Cited by 701
Cited by
Items 201–300 of 764
Köller, H., Schroeter, M., Kieseier, B. C., & Hartung, H. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000169744.14288.d1 · Cited by 44
Inflammatory Cytokines Are Involved in Focal Demyelination in Leprosy Neuritis
Andrade, P. R., Jardim, M. R., Costa-da-Silva, A. C., Manhães, P. S., Antunes, S. L. G., Vital, R. T., Prata, R. B. D. S., Petito, R. B., Pinheiro, R. O., & Sarno, E. N. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlv027 · Cited by 43
Fluid supported lipid bilayers containing monosialoganglioside GM1: A QCM-D and FRAP study
Weng, K. C., Kanter, J. L., Robinson, W. H., & Frank, C. W. (2006) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2006.03.010 · Cited by 43
Prognostic factors for the sequelae and severity of Guillain‐Barré syndrome in children
Estrade, S., Guiomard, C., Fabry, V., Baudou, É., Cancés, C., Chaix, Y., Cintas, P., Meyer, P., & Cheuret, E. (2019) · Muscle & Nerve · doi:10.1002/mus.26706 · Cited by 42
Toxemia in Human Naturally Acquired Botulism
Rasetti‐Escargueil, C., Lemichez, E., & Popoff, M. R. (2020) · Toxins · doi:10.3390/toxins12110716 · Cited by 42
What's new in Guillain-Barré syndrome?
Pritchard, J. (2008) · Postgraduate Medical Journal · doi:10.1136/jnnp.2006.097709 · Cited by 42
Ganglioside Inhibition of Neurite Outgrowth Requires Nogo Receptor Function
Williams, G., Wood, A., Williams, E.-J., Gao, Y., Mercado, M. L., Katz, A., Joseph-McCarthy, D., Bates, B., Ling, H.-P., Aulabaugh, A., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802067200 · Cited by 37
Fujikawa, K., Nakashima, S., Konishi, M., Fuse, T., Komura, N., Ando, T., Ando, H., Yuki, N., Ishida, H., & Kiso, M. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201003357 · Cited by 41
Prospective study on anti-ganglioside antibodies in childhood Guillain-Barre syndrome
Schessl, J., Koga, M., Funakoshi, K., Kirschner, J., Muellges, W., Weishaupt, A., Gold, R., & Korinthenberg, R. (2006) · Archives of Disease in Childhood · doi:10.1136/adc.2006.098061 · Cited by 41
Identification of Gene Networks and Pathways Associated with Guillain-Barré Syndrome
Chang, K., Chuang, T.-J., Lyu, R., Ro, L., Wu, Y., Chang, H., Huang, C.-C., Kuo, H., Hsu, W., Chu, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029506 · Cited by 40
Pritchard, J. (2010) · Clinical Medicine · doi:10.7861/clinmedicine.10-4-399 · Cited by 40
Goodfellow, J. A., & Willison, H. J. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000361 · Cited by 40
Self-citationLéger, J., & Béhin, A. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000175937.31569.15 · Cited by 40
Acute Lower Motor Neuron Tetraparesis
Añor, S. (2014) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2014.07.010 · Cited by 39
Hide and Seek: The Interplay Between Zika Virus and the Host Immune Response
Lee, L. J., Komarasamy, T. V., Adnan, N. A. A., James, W., & Balasubramaniam, V. R. M. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.750365 · Cited by 39
Sialylated intravenous immunoglobulin suppress anti-ganglioside antibody mediated nerve injury
Zhang, G., Massaad, C. A., Gao, T., Pillai, L., Bogdanova, N., Ghauri, S., & Sheikh, K. A. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.020 · Cited by 38
“Autoantibodies directed against gangliosides expressed on neuronal cell surfaces have become the main focus of research in GBS (Ilyas et al., 1988; Quarles et al., 1990; Willison and Yuki, 2002).”
BackgroundScendoni, R., Petrelli, C., Scaloni, G., & Logullo, F. O. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1954826 · Cited by 38
Gangliosides and Autoimmune Peripheral Nerve Diseases
Goodfellow, J. A., & Willison, H. J. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.12.010 · Cited by 38
Self-citationImmunoglobulin for multifocal motor neuropathy
Keddie, S., Eftimov, F., van den Berg, L. H., Brassington, R., de Haan, R. J., & van Schaik, I. N. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004429.pub3 · Cited by 38
Campbell, A. W., Thrasher, J. D., Madison, R., Vojdani, A., Gray, M. R., & Johnson, A. (2003) · Archives of Environmental Health An International Journal · doi:10.3200/aeoh.58.8.464-474 · Cited by 38
Microarray screening of Guillain-Barré syndrome sera for antibodies to glycolipid complexes
Halstead, S. K., Kalna, G., Islam, M. B., Jahan, I., Mohammad, Q. D., Jacobs, B. C., Endtz, H. P., Islam, Z., & Willison, H. J. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000284 · Cited by 38
Self-citationTreatment of dysimmune neuropathies
Nobile‐Orazio, E. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0805-0 · Cited by 38
Iglesias‐Bartolomé, R., Crespo, P. M., Gomez, G. A., & Daniotti, J. L. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05194.x · Cited by 37
Isolated abducens nerve palsy as a regional variant of Guillain–Barré syndrome
Tatsumoto, M., Odaka, M., Hirata, K., & Yuki, N. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.11.026 · Cited by 37
Successful treatment with rituximab of one patient with CANOMAD neuropathy
Delmont, É., Jeandel, P. Y., Hubert, A. M., Marcq, L., Boucraut, J., & Desnuelle, C. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5412-z · Cited by 37
Houliston, R. S., Yuki, N., Hirama, T., Khieu, N. H., Brisson, J., Gilbert, M., & Jarrell, H. C. (2007) · Biochemistry · doi:10.1021/bi062001v · Cited by 37
Gangliosides in Axon Stability and Regeneration
López, P. H. H., & Báez, B. B. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.03.001 · Cited by 36
Asthana, P., Zhang, G., Sheikh, K. A., & Ma, C. H. E. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.08.020 · Cited by 36
Zhang, G., Lehmann, H. C., Богданова, Н. А., Gao, T., Zhang, J., & Sheikh, K. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027067 · Cited by 36
Iglesias‐Bartolomé, R., Trenchi, A., Comín, R., Moyano, A. L., Nores, G. A., & Daniotti, J. L. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.09.018 · Cited by 36
Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials
Alexopoulos, H., Biba, A., & Dalakas, M. C. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0402-6 · Cited by 36
Anti‐ganglioside antibodies and elevated CSF IgG levels in Guillain‐Barré syndrome
Matà, S., Galli, E., Amantini, A., Pinto, F., Sorbi, S., & Lolli, F. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01161.x · Cited by 36
Yao, J., Zhou, R., Liu, Y., & Lu, Z. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2215153 · Cited by 35
Guillain–Barré syndrome in Colombia: where do we stand now?
Mahecha, M. P., Ojeda, E., Vega, D. A., Sarmiento-Monroy, J. C., & Anaya, J. (2016) · Immunologic Research · doi:10.1007/s12026-016-8816-8 · Cited by 35
Anti-Ganglioside Antibodies in Amyotrophic Lateral Sclerosis Revisited
Kollewe, K., Wurster, U., Sinzenich, T., Körner, S., Dengler, R., Mohammadi, B., & Petri, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125339 · Cited by 35
Horwacik, I., & Rokita, H. (2015) · APOPTOSIS · doi:10.1007/s10495-015-1103-7 · Cited by 35
Pathophysiology of autoimmune polyneuropathies
Dalakas, M. C. (2013) · La Presse Médicale · doi:10.1016/j.lpm.2013.01.058 · Cited by 35
Sharma, M. B., Chaudhry, R., Tabassum, I., Ahmed, N. H., Sahu, J. K., Dhawan, B., & Kalra, V. (2011) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.1508 · Cited by 35
Immunoadsorption and Plasma Exchange in Seropositive and Seronegative Immune-Mediated Neuropathies
Davies, A. J., Fehmi, J., Şenel, M., Tumani, H., Dorst, J., & Rinaldi, S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072025 · Cited by 35
Guillain-Barré Syndrome and Campylobacter Infection
Jacobs, B. C., van Belkum, A., & Endtz, H. P. (2014) · ASM Press eBooks · doi:10.1128/9781555815554.ch13 · Cited by 35
Boffey, J., Odaka, M., Nicoll, D., Wagner, E. R., Townson, K. H., Bowes, T., Conner, J., Furukawa, K., & Willison, H. J. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.04.011 · Cited by 35
Self-citationGuillain-Barre syndrome following COVID-19 vaccines: A review of literature
Yu, M., Nie, S., Qiao, Y., & Ma, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1078197 · Cited by 34
Sialic acids in infection and their potential use in detection and protection against pathogens
Dedola, S., Ahmadipour, S., de Andrade, P., Baker, A. N., Boshra, A. N., Chessa, S., Gibson, M. I., Hernando, P. J., Ivanova, I. M., Lloyd, J., et al. (2024) · RSC Chemical Biology · doi:10.1039/d3cb00155e · Cited by 34
Kwak, D. H., Kim, S. M., Lee, D. H., Kim, J. S., Kim, S. M., Lee, S., Jung, K. Y., Seo, B. B., & Choo, Y. K. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)13238-9 · Cited by 34
Changes in the neuromuscular synapse induced by an antibody against gangliosides
Santafé, M. M., Sabaté, M. M., García, N., Ortiz, N., Lanuza, M. A., & Tomàs, J. M. (2005) · Annals of Neurology · doi:10.1002/ana.20403 · Cited by 34
Ganglioside complexes: new autoantibody targets in Guillain–Barré syndromes
Willison, H. J. (2005) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0001 · Cited by 34
Self-citationNeurophysiological approach to disorders of peripheral nerve
Crone, C., & Krarup, C. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52902-2.00006-0 · Cited by 33
Associated autoimmune diseases in patients with multifocal motor neuropathy and their family members
Cats, E. A., Bertens, A. S., Veldink, J. H., van den Berg, L. H., & van der Pol, W. L. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6315-3 · Cited by 33
Anti-GM1 antibodies as a model of the immune response to self-glycans
Nores, G. A., Lardone, R. D., Comín, R., Alaniz, M. E., Moyano, A. L., & Irazoqui, F. J. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.09.008 · Cited by 33
Anti-GD2-like IgM autoreactivity in multiple sclerosis patients
Marconi, S., Acler, M., Lovato, L., Toni, L. D., Tedeschi, E., Anghileri, E., Romito, S., Cordioli, C., & Bonetti, B. (2006) · Multiple Sclerosis Journal · doi:10.1191/135248506ms1279oa · Cited by 33
Therapeutic Strategies in the Guillain-Barré Syndrome
Kieseier, B. C., & Hartung, H. (2003) · Seminars in Neurology · doi:10.1055/s-2003-41132 · Cited by 33
Heikema, A. P., Jacobs, B. C., Horst-Kreft, D., Huizinga, R., Kuijf, M. L., Endtz, H. P., Samsom, J. N., & van Wamel, W. J. B. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12073 · Cited by 32
“In agreement with this observation, antibodies against monosialylated structures, including GM1a, GM1b, GD1a and GalNAc-GD1a, are frequently detected in the serum of GBS patients [13,14].”
Zika Virus as an Emerging Neuropathogen: Mechanisms of Neurovirulence and Neuro-Immune Interactions
Morris, G., Barichello, T., Stubbs, B., Köhler, C. A., Carvalho, A. F., & Maes, M. H. J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0635-y · Cited by 33
Intravenous Immunoglobulin Treatment in Multifocal Motor Neuropathy
van der Pol, W. L., Cats, E. A., & van den Berg, L. H. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9408-3 · Cited by 32
Conduction block in immune‐mediated neuropathy: paranodopathy versus axonopathy
Garg, N., Park, S. B., Howells, J., Vucic, S., Yiannikas, C., Mathey, E. K., Nguyen, T. N., Noto, Y., Barnett, M. H., Krishnan, A. V., et al. (2019) · European Journal of Neurology · doi:10.1111/ene.13953 · Cited by 32
Apoptosis of primary sensory neurons in GD1b-induced sensory ataxic neuropathy
Takada, K., Shimizu, J., & Kusunoki, S. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.09.010 · Cited by 32
Ca2+-dependent anti-GQ1b antibody in GQ1b-seronegative Fisher syndrome and related disorders
Uchibori, A., Gyohda, A., & Chiba, A. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.07.021 · Cited by 31
Boffey, J., Nicholl, D., Wagner, E. R., Townson, K. H., Goodyear, C. S., Furukawa, K., Furukawa, K., Conner, J., & Willison, H. J. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.04.002 · Cited by 31
Self-citationPaton, A. W., Morona, R., & Paton, J. C. (2010) · Bioengineered Bugs · doi:10.4161/bbug.1.3.10665 · Cited by 31
Abnormal antibodies to self-carbohydrates in SARS-CoV-2-infected patients
Butler, D. L., Imberti, L., Quaresima, V., Fiorini, C., Barnett, J., Chauvin, S. D., Cheng, X., Danielson, J. J., Dobbs, K., Garabedian, E., et al. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac062 · Cited by 30
Monoclonal gammopathy and neuropathy
Lozeron, P., & Adams, D. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282ef79e3 · Cited by 30
Fcγ Receptor-Mediated Inflammation Inhibits Axon Regeneration
Zhang, G., Богданова, Н. А., Gao, T., Song, J. J., Cragg, M. S., Glennie, M. J., & Sheikh, K. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088703 · Cited by 30
Bader, S. R., Kothlow, S., Trapp, S., Schwarz, S. C., Philipp, H.-C., Weigend, S., Sharifi, A. R., Preisinger, R., Schmahl, W., Kaspers, B., et al. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-7 · Cited by 30
Diagnostic Utility of Auto Antibodies in Inflammatory Nerve Disorders
Delmont, É., & Willison, H. J. (2015) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-150078 · Cited by 30
Self-citationTrauma-Related Guillain–Barré Syndrome: Systematic Review of an Emerging Concept
Huang, C., Zhang, Y., Deng, S., Ren, Y., & Lu, W. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.588290 · Cited by 30
Vlam, L., Piepers, S., Sutedja, N. A., Jacobs, B. C., Tio‐Gillen, A. P., Stam, M., Franssen, H., Veldink, J. H., Cats, E. A., Notermans, N. C., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7612-4 · Cited by 30
Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain–Barré syndrome
Csurhes, P. A., Sullivan, A.-A., Green, K., Greer, J. M., Pender, M. P., & McCombe, P. (2005) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2004.04.006 · Cited by 30
Clonality of anti-GM1 IgM antibodies in multifocal motor neuropathy and the Guillain-Barré syndrome
Cats, E. A., van der Pol, W. L., Tio‐Gillen, A. P., Diekstra, F. P., van den Berg, L. H., & Jacobs, B. C. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308118 · Cited by 29
Zika virus infection in the returning traveller: what every neurologist should know
Leonhard, S. E., Lant, S. B., Jacobs, B. C., Wilder‐Smith, A., Ferreira, M. L. B., Solomon, T., & Willison, H. J. (2018) · Practical Neurology · doi:10.1136/practneurol-2017-001789 · Cited by 29
Self-citationPritchard, J., & Hughes, R. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16512-4 · Cited by 29
Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome
van Sorge, N. M., van der Pol, W. L., Jansen, M., & van den Berg, L. H. (2003) · Autoimmunity Reviews · doi:10.1016/s1568-9972(03)00089-2 · Cited by 29
Selmi, C. F., Papini, A. M., Pugliese, P., Alcaro, M. C., & Gershwin, M. E. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.23398 · Cited by 28
Guillain–Barre syndrome: First description of a snake envenomation aetiology
Neil, J., Choumet, V., Coupanec, A. L., d’Alayer, J., Demeret, S., & Musset, L. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.11.007 · Cited by 28
Anti-GM1 antibodies affect the integrity of lipid rafts
Ueda, A., Shima, S., Miyashita, T., Ito, S., Ueda, M., Kusunoki, S., Asakura, K., & Mutoh, T. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.07.008 · Cited by 28
Siddiqui, K., Cahalane, E., Keogan, M. T., & Hardiman, O. M. (2003) · Neurology · doi:10.1212/wnl.61.9.1307 · Cited by 28
Chronic Demyelinating Polyneuropathies
Allen, J. A. (2017) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000517 · Cited by 28
Gastaldi, M., Zardini, E., Scaranzin, S., Uccelli, A., Andreetta, F., Baggi, F., & Franciotta, D. M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2019.01385 · Cited by 28
Gangliosides as targets for autoimmune injury to the nervous system
Willison, H. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04718.x · Cited by 28
Self-citationCDR3 spectratyping analysis of the T cell receptor repertoire in Guillain–Barré and Fisher syndromes
Koga, M., Yuki, N., Tsukada, Y., Hirata, K., & Matsumoto, Y. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00212-1 · Cited by 28
B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders
Stübgen, J. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.07.019 · Cited by 28
Wieczorek, A., Manzitti, C., Garaventa, A., Gray, J. C., Papadakis, V., Valteau‐Couanet, D., Zachwieja, K., Pöetschger, U., Pribill, I., Fiedler, S., et al. (2022) · Cancers · doi:10.3390/cancers14081919 · Cited by 27
Heteromeric glycolipid complexes as modulators of autoantibody and lectin binding
Rinaldi, S., Brennan, K. M., & Willison, H. J. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.09.001 · Cited by 27
Self-citationTumor necrosis factor‐α‐converting enzyme is expressed in the inflamed peripheral nervous system
Kurz, M., Pischel, H., Hartung, H., & Kieseier, B. C. (2005) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2005.10309.x · Cited by 27
Immunoglobulin improves a model of acute motor axonal neuropathy by preventing axonal degeneration
Nishimoto, Y., Koga, M., Kamijo, M., Hirata, K., & Yuki, N. (2004) · Neurology · doi:10.1212/01.wnl.0000129917.28461.0c · Cited by 27
Galban‐Horcajo, F., Halstead, S. K., McGonigal, R., & Willison, H. J. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.01.008 · Cited by 26
Self-citationComposite ganglioside autoantibodies and immune treatment response in MMN and MADSAM
Martinez‐Thompson, J. M., Snyder, M. R., Ettore, M. W., McKeon, A. B., Pittock, S. J., Roforth, M. M., Mandrekar, J. N., Mauermann, M. L., Taylor, B. V., Dyck, P. J. B., et al. (2017) · Muscle & Nerve · doi:10.1002/mus.26051 · Cited by 26
Funakoshi, K., Koga, M., Takahashi, M., Hirata, K., & Yuki, N. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.02.010 · Cited by 26
Autoimmune‐mediated polyneuropathy triggered by borrelial infection?
Rupprecht, T. A., Elstner, M., Weil, S., & Pfister, H. (2008) · Muscle & Nerve · doi:10.1002/mus.20929 · Cited by 26
Carr, K. R., Shah, M., Garvin, R., Shakir, A., & Jackson, C. E. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2014.957760 · Cited by 26
IVIg in idiopathic autoimmune neuropathies: analysis in the light of the latest results
Nobile‐Orazio, E., & Terenghi, F. (2005) · Journal of Neurology · doi:10.1007/s00415-005-1103-6 · Cited by 26
Role of immunologic cross-reactivity in neurological diseases
Ercolini, A. M., & Miller, S. D. (2005) · Neurological Research · doi:10.1179/016164105x49508 · Cited by 26
Anti-tissue transglutaminase IgA antibodies in peripheral neuropathy and motor neuronopathy
Matà, S., Renzi, D., Pinto, F., & Calabro, A. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00602.x · Cited by 26
Anti‐ganglioside Antibodies and the Presynaptic Motor Nerve Terminal
Willison, H. J., & Plomp, J. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1405.010 · Cited by 25
Self-citationImmune Pathogenesis and Treatment of Multifocal Motor Neuropathy
Vlam, L., van den Berg, L. H., Cats, E. A., Piepers, S., & van der Pol, W. L. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9779-8 · Cited by 25
Guillain‐Barré syndrome associated with CASPR2 antibodies: two paediatric cases
Rosch, R. E., Bamford, A., Hacohen, Y., Wraige, E., Vincent, A. C., Mewasingh, L., & Lim, M. J. (2014) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12089 · Cited by 25
Neuromuscular synaptic function in mice lacking major subsets of gangliosides
Zitman, F. M. P., Todorov, B., Jacobs, B. C., Verschuuren, J. J. G. M., Furukawa, K., Furukawa, K., Willison, H. J., & Plomp, J. J. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.034 · Cited by 25
Self-citationEffector mechanisms in anti-MAG antibody-mediated and other demyelinating neuropathies
Latov, N., & Renaud, S. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.03.012 · Cited by 25
Mihara, T., Ueda, A., Hirayama, M., Takeuchi, T., Yoshida, S., Naito, K., Yamamoto, H., & Mutoh, T. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.08.013 · Cited by 25
Guillain–Barré syndrome: update on immunobiology and treatment
Kaida, K., & Kusunoki, S. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.77 · Cited by 25
Usuki, S., Thompson, S. A., Rivner, M. H., Taguchi, K., Shibata, K., Ariga, T., & Yu, R. K. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20717 · Cited by 25
Metadata
- Authors
- Willison, H. J.
- Affiliations
- Southern General Hospital (GB)
- Corresponding author
- Willison, H. J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-12-01
- Volume
- 125
- Issue
- 12
- Pages
- 2591-2625
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2021949020
- Cited by
- 710
- References
- 286
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 19 · 2023: 22 · 2022: 16 · 2021: 21 · 2020: 19 · 2019: 12 · 2018: 20 · 2017: 23 · 2016: 34 · 2015: 30 · 2014: 37 · 2013: 32 · 2012: 33
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- anti-glycolipid antibodies, peripheral neuropathy, Guillain-Barré syndrome, Miller Fisher syndrome, acute motor axonal neuropathy, gangliosides, GM1, GD1a, GQ1b, Campylobacter jejuni, molecular mimicry, sensory neuropathy, immunomodulatory therapy
- MeSH terms
- Animals, Autoantibodies, Glycolipids, Humans, Immunoglobulin G, Immunoglobulin M, Peripheral Nervous System Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.